MedPath

Levonorgestrel and Ethinyl Estradiol

Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15mg/0.03 mg

Approved
Approval ID

ea9f7216-0358-43a9-96eb-5dad694ae9b8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 5, 2023

Manufacturers
FDA

Naari Pte Limited

DUNS: 659345996

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code79929-003
Application NumberANDA207033
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel and Ethinyl Estradiol
Product Specifications
Effective DateApril 5, 2023
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Levonorgestrel and Ethinyl Estradiol - FDA Drug Approval Details